ARTICLE | Finance

Big band swing

Biotech winners, losers in 4Q15

January 4, 2016 8:00 AM UTC

Many investors treated biotech's dismal 3Q15 as a buying opportunity, and the effects were apparent in 4Q15. All of the market cap bands showed positive gains save for the microcaps.

Big biotechs led the charge with a 15.7% spike in 4Q15 and ended the year up 7.2%. ...